| | - How the demise of a California biotech firm actually benefited two of its publicly traded REIT landlords
- The opening of $100 million-plus research facilities in California and Utah
- Plans to expand a controversial biopark in Massachusetts to more than 1 million square feet of space
- Ernst & Young’s predictions regarding the future of the bio business, as presented at the BIO 2009 conference
- More BIO 2009 coverage: Why biotech expert Steve Burrill thinks the industry has changed for good
- What a leading investment banker told the AURP BioParks 2009 conference about the capital markets
- Bioscience real estate transactions, projects, economic development, companies and people news from North Carolina, Seattle, New York, Nebraska, Maryland, New Jersey, Oregon, Virginia, Pennsylvania, Massachusetts, California, Minnesota, Wisconsin, Michigan, Kansas, Alaska, New Mexico, Illinois, Oklahoma, Ohio, Florida, Indiana, Missouri, Georgia, Colorado and more.
|
At Bioscience Real Estate Insights, we define the biosciences – or life sciences, as some call them – as the scientific study of living things. The real estate development, financing and investment issues associated with the pharma, biotech and medical devices sectors are unique, and they deserve our specialized editorial focus. This national, B2B newsletter offers the most comprehensive coverage in the industry. For more information regarding BREI, please visit us at '/>"/>
.
.
.
.
.
.
.
.
.
.
.